# Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury

> **NCT00555009** · PHASE4 · TERMINATED · sponsor: **Pfizer** · enrollment: 10 (actual)

## Conditions studied

- Brain Injuries
- Growth Hormone Deficiency

## Interventions

- **DRUG:** Genotropin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00555009
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-03
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** See termination reason in detailed description.
- **Last updated:** 2010-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00555009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00555009, "Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00555009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*